1. Zdr Varst. 2015 Mar 13;54(2):86-90. doi: 10.1515/sjph-2015-0013. eCollection 
2015 Jun.

Newborn Screening in Slovenia.

Šmon A(1), Grošelj U(1), Žerjav Tanšek M(1), Biček A(2), Oblak A(2), Zupančič 
M(3), Kržišnik C(4), Repič Lampr Et B(3), Murko S(3), Hojker S(2), Battelino 
T(5).

Author information:
(1)University Medical Centre Ljubljana, University Children's Hospital, 
Department of Endocrinology, Diabetes and Metabolic Diseases, Bohoriceva 20, 
1000 Ljubljana, Slovenia.
(2)University Medical Centre Ljubljana, Department of Nuclear Medicine, Zaloska 
cesta 7, 1000 Ljubljana, Slovenia.
(3)University Medical Centre Ljubljana, University Children's Hospital, Unit for 
Special Laboratory Diagnostics, Vrazov trg 1, 1000 Ljubljana, Slovenia.
(4)University of Ljubljana, Faculty of Medicine, Vrazov trg 2, 1000 Ljubljana, 
Slovenia.
(5)University Medical Centre Ljubljana, University Children's Hospital, 
Department of Endocrinology, Diabetes and Metabolic Diseases, Bohoriceva 20, 
1000 Ljubljana, Slovenia; University of Ljubljana, Faculty of Medicine, Vrazov 
trg 2, 1000 Ljubljana, Slovenia.

INTRODUCTION: Newborn screening in whole Slovenia started in 1979 with screening 
for phenylketonuria (PKU). Congenital hypothyroidism (CH) was added into the 
programme in 1981. The aim of this study was to analyse the data of neonatal 
screening in Slovenia from 1993 to 2012 for PKU, and from 1991 to 2012 for CH.
METHODS: Blood samples were collected from the heels of newborns between the 
third and the fifth day after birth. Fluorometric method was used for screening 
for PKU, CH screening was done by dissociation-enhanced lanthanide fluorescent 
immunoassay (DELFIA).
RESULTS: From 1993 to 2012, from 385,831 newborns 57 were identified with PKU. 
184 newborns out of 427,396 screened from 1991 to 2012, were confirmed for CH. 
Incidences of PKU and CH in the periods stated are 1:6769 and 1:2323, 
respectively.
CONCLUSIONS: Successful implementation of newborn screening for PKU and CH has 
helped in preventing serious disabilities of the affected children. Adding 
screening for new metabolic diseases in the future would be beneficial.

Publisher: UVOD: Presejanje novorojencev v Sloveniji se je začelo leta 1979 s 
presejanjem za fenilketonurijo (PKU). Leta 1981 je bil v program presejanja 
dodan še kongenitalni hipotireoidizem (CH). Cilj te raziskave je analiza 
podatkov presejanja novorojencev v Sloveniji v obdobju med letoma 1993 in 2012 
za PKU ter med letoma 1991 in 2012 za CH.
METODE: Vzorci krvi so bili odvzeti petim novorojencem med tretjim in petim dnem 
življenja. Pri presejanju za PKU se uporablja fluorometrična metoda, presejanje 
za CH pa poteka z metodo DELFIA.
REZULTATI: Od leta 1993 do leta 2012 je bil presejalni test za PKU izveden pri 
358.831 novorojencih. Pri 57 otrocih je bil PKU potrjen. Pri 427.396 
novorojencih med letoma 1991 in 2012 je bil izveden presejalni test za CH. Pri 
184 otrocih je bil CH potrjen. V navedenih obdobjih je bila incidenca PKU 1:6769 
in incidenca CH 1:2323.
ZAKLJUČKI: Uspešna implementacija presejanja novorojencev za PKU in CH je imela 
pomembno vlogo pri preprečevanju resnih zapletov pri obolelih otrocih. Smiselno 
bi bilo v program presejanja vključiti nove metabolne bolezni.

DOI: 10.1515/sjph-2015-0013
PMCID: PMC4820172
PMID: 27646913